The therapeutic approach involves modifying human platelets to create “decoys” that are still capable of binding to some cells but will not aggregate or carry out the other normal platelet functions, including chemical signalling associated with the clotting process.
from Hindustan Times - health-fitness http://bit.ly/2BzA0VW
Post Top Ad
Thursday, 14 February 2019
Now, reversible antiplatelet therapy to fight clotting, cancer metastasis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment